TrialCancer communications (London, England)2024

HLX07 alone or combined with serplulimab, cisplatin and 5-fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 study.

Yun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.